Publicaciones en colaboración con investigadores/as de Hospital Italiano de Buenos Aires (21)

2023

  1. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

    eClinicalMedicine, Vol. 65

2022

  1. Guiding the global evolution of cytogenetic testing for hematologic malignancies

    Blood, Vol. 139, Núm. 15, pp. 2273-2284

  2. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study

    Liver International, Vol. 42, Núm. 8, pp. 1891-1901

2021

  1. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

    Blood, Vol. 137, Núm. 14, pp. 1879-1894

  2. Cranberry dosed extract: An effective therapy for recurrent Escherichia coli cystitis in elderly patients. The GerHogar Cysticlean® study

    Revista Colombiana de Nefrologia, Vol. 8, Núm. 1

  3. Factors Associated with Survival and Survival without Major Morbidity in Very Preterm Infants in Two Neonatal Networks: SEN1500 and NEOCOSUR

    Neonatology, Vol. 118, Núm. 3, pp. 289-296

  4. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  5. Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  6. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

  7. Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials

    Hematological Oncology, Vol. 39, Núm. 4, pp. 529-538

2020

  1. International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

    Blood Cancer Journal, Vol. 10, Núm. 10

2018

  1. National clinical practice guidelines for allergen immunotherapy: An international assessment applying AGREE-II

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 3, pp. 664-672

  2. Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients

    British Journal of Haematology, Vol. 180, Núm. 6, pp. 831-839

2017

  1. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367

2016

  1. Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice

    American Journal of Hematology, Vol. 91, Núm. 6, pp. 575-580

  2. Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients

    Leukemia and Lymphoma, Vol. 57, Núm. 9, pp. 2071-2076

2015

  1. Future research and clinical directions in the field of men's mental health: The madrid declaration

    Neurobiology of Men's Mental Health (Nova Science Publishers, Inc.), pp. 323-327

2014

  1. Future research and clinical directions in the field of men's mental health: The Madrid declaration

    Frontiers in Public Health

2013

  1. Plasma cell leukemia: Consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

    Leukemia, Vol. 27, Núm. 4, pp. 780-791

2012

  1. Acute loss of vision as the initial symptom of multiple myeloma

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 12, Núm. 2, pp. 148-150